CYP19A1 and colorectal carcinoma: It has been reported that aberrant expression of the lipid metabolism differential gene CYP19A1 in CRC is not only a prognostic risk factor for CRC patients but also enhances the ability of activated CD8+ T cells to kill CRC cells by suppressing the expression of PD-L1 in CRC cells [50].